| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.31M | 18.54M | 12.66M | 19.03M | 18.16M | 13.66M |
| Gross Profit | 5.60M | 5.31M | 2.78M | 4.15M | 3.97M | 2.74M |
| EBITDA | -1.11M | -2.02M | -3.24M | -1.77M | -1.86M | -1.57M |
| Net Income | -793.43K | -1.37M | -2.82M | -1.32M | -3.12M | -1.80M |
Balance Sheet | ||||||
| Total Assets | 43.19M | 41.28M | 42.84M | 48.19M | 50.98M | 51.72M |
| Cash, Cash Equivalents and Short-Term Investments | 30.42M | 32.20M | 33.28M | 25.86M | 42.23M | 41.98M |
| Total Debt | 2.24M | 237.79K | 584.36K | 819.47K | 1.08M | 1.31M |
| Total Liabilities | 4.66M | 1.94M | 1.87M | 3.14M | 3.18M | 2.25M |
| Stockholders Equity | 38.53M | 39.35M | 40.97M | 45.06M | 47.80M | 49.47M |
Cash Flow | ||||||
| Free Cash Flow | -1.26M | 236.11K | -1.31M | -5.17M | 94.09K | -21.37K |
| Operating Cash Flow | -597.03K | 1.10M | 316.99K | -4.90M | 474.07K | 226.78K |
| Investing Cash Flow | 6.11M | 3.47M | 2.00M | -31.15M | 24.69M | 9.75M |
| Financing Cash Flow | -1.79M | -1.73M | -2.27M | -1.51M | 474.28K | -1.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
57 Neutral | C$16.03M | -11.67 | -61.05% | ― | -15.84% | -375.96% | |
53 Neutral | C$123.80M | -23.80 | -2.95% | 3.07% | 5.06% | 93.02% | |
52 Neutral | C$188.43M | -20.59 | -92.59% | ― | 6.29% | -3.71% | |
49 Neutral | C$223.00M | -206.22 | -2.11% | ― | 30.76% | 52.23% | |
45 Neutral | C$126.74M | -8.90 | -64.59% | ― | ― | 56.03% | |
28 Underperform | C$6.22M | -236.36 | ― | ― | ― | 91.27% |
EcoSynthetix reported a 11% increase in net sales for Q3 2025, driven by higher volumes and new commercial accounts in Europe for its SurfLock™ strength aids. The company maintained a strong balance sheet with $30.4 million in cash and term deposits, and is positioned for long-term growth with strategic partnerships in key markets.
EcoSynthetix Inc. has secured two new tissue line contracts in Europe for its bio-based strength aid, SurfLock™, through a partnership with RNM Group. This development highlights the growing recognition of SurfLock™’s value in strengthening paper applications while using cost-effective or recycled materials, enhancing EcoSynthetix’s market position and expanding its reach in the tissue industry.